International Patent: PARENTERAL KETAMINE FORMULATIONS AND METHODS THEREOF

GENEVA, Nov. 6 -- NRX PHARMACEUTICALS, INC. filed a patent application (US2026/026236) for “PARENTERAL KETAMINE FORMULATIONS AND METHODS THEREOF”. With publication no. WO/2026/232044, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/13

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....